UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000048345
Receipt number R000055100
Scientific Title The research on impact of attributes of people with mental disorder on treatment stigma
Date of disclosure of the study information 2022/07/12
Last modified on 2022/07/12 10:48:48

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The research on impact of attributes of people with mental disorder on treatment stigma

Acronym

The research on impact of attributes of people with mental disorder on treatment stigma

Scientific Title

The research on impact of attributes of people with mental disorder on treatment stigma

Scientific Title:Acronym

The research on impact of attributes of people with mental disorder on treatment stigma

Region

Japan


Condition

Condition

Mental disorders

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the impact of gender, age, and other attributes of people with mental disorders on their treatment stigma through an online survey.

Basic objectives2

Others

Basic objectives -Others

Online survey

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Total and subscale scores of Barriers to Access to Care Evaluation scale version3(BACEv3) Japanese version.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >=

Gender

Male and Female

Key inclusion criteria

This study is based on secondary use of data collected by Hongo et al. during the course of the study, "Reliability and Validity of the Japanese Version of the Barriers to Access to Care Evaluation Scale Version 3 for People With Mental Disorders: an Online Survey Study"(https://doi.org/10.3389/fpsyg.2021.760184). The inclusion criteria of Hongo's study is as follows.

(1) People who have been present with full explanation about the study, and have given their free and voluntary consent based on a thorough understanding of the study.

(2) People who are between 20 and 65 years of age at the time of obtaining consent.

Key exclusion criteria

(1) People with intellectual disability, dementia, positive symptoms of schizophrenia, people at imminent risk of suicide, or people deemed inappropriate by the therapist or examiner.

Target sample size

260


Research contact person

Name of lead principal investigator

1st name Fumiyo
Middle name
Last name Oshima

Organization

Chiba University

Division name

Research Center for Child Mental Development

Zip code

260-8677

Address

1-8-1, Inohana, Chuou-ku. Chiba-shi, Chiba, Japan.

TEL

043-226-2975

Email

c21ujsw35117c@faculty.gs.chiba-u.jp


Public contact

Name of contact person

1st name Masaki
Middle name
Last name Tamura

Organization

Chiba University

Division name

Department of Cognitive Behavioral Physiology

Zip code

260-8677

Address

1-8-1, Inohana, Chuou-ku. Chiba-shi, Chiba, Japan

TEL

043-226-2027

Homepage URL


Email

m.tamura.cmc@chiba-u.jp


Sponsor or person

Institute

Chiba University

Institute

Department

Personal name



Funding Source

Organization

Ministry of education

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Ethics Review Committee of the Graduate School of Medicine, Chiba University

Address

1-8-1, Inohana, Chuou-ku. Chiba-shi, Chiba, Japan

Tel

043-226-2027

Email

inohana-rinri@chiba-u.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 07 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

268

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2022 Year 06 Month 23 Day

Date of IRB

2022 Year 06 Month 23 Day

Anticipated trial start date

2022 Year 06 Month 23 Day

Last follow-up date

2022 Year 06 Month 23 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Secondary statistical analysis will be performed on the results of a web-based survey (including background information such as age, gender, and primary diagnosis, as well as the Japanese version of the Barriers to Access to Care Evaluation scale v3 (BACEv3)).


Management information

Registered date

2022 Year 07 Month 12 Day

Last modified on

2022 Year 07 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055100